Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 4 boards, counting each seat separately. Longest: Neurogene Inc., 3 years.
Neurogene Inc.
Director
Prelude Therapeutics Incorporated
Director
Alumis Inc.
Director · President, CEO and Chairman
MapLight Therapeutics Inc.
Director
Chief executive roles
Alumis Inc.
· President, CEO and Chairman
Since June 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2026 | MapLight Therapeutics Inc. | Grant or award | +7,864 | — | — |
| Apr 1, 2025 | Alumis Inc. | Open-market purchase | +15,650 | $6.44 | $100,786 |
| Jul 1, 2024 | Alumis Inc. | Sold back to the company | −90,804 | — | — |
| Jul 1, 2024 | Alumis Inc. | Grant or award | +90,804 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.